Jocelyn Dupuis

Jocelyn Dupuis

Université de Montréal

H-index: 47

North America-Canada

About Jocelyn Dupuis

Jocelyn Dupuis, With an exceptional h-index of 47 and a recent h-index of 24 (since 2020), a distinguished researcher at Université de Montréal, specializes in the field of pulmonary vascular disease, pulmonary hypertension, heart failure, molecular imaging.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods of treating acute respiratory distress syndrome using colchicine

Extracellular vesicles in venous thromboembolism and pulmonary hypertension

Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia

Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation

Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke–Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFκB (Nuclear Factor κB …

Fourteen-day evolution of COVID-19 symptoms during the third wave in nonvaccinated subjects and effects of hesperidin therapy: a randomized, double-blinded, placebo-controlled …

Orally‐administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers

Jocelyn Dupuis Information

University

Position

Full professor department of Medicine

Citations(all)

13748

Citations(since 2020)

2850

Cited By

12415

hIndex(all)

47

hIndex(since 2020)

24

i10Index(all)

113

i10Index(since 2020)

49

Email

University Profile Page

Université de Montréal

Google Scholar

View Google Scholar Profile

Jocelyn Dupuis Skills & Research Interests

pulmonary vascular disease

pulmonary hypertension

heart failure

molecular imaging

Top articles of Jocelyn Dupuis

Title

Journal

Author(s)

Publication Date

Methods of treating acute respiratory distress syndrome using colchicine

2023/12/19

Extracellular vesicles in venous thromboembolism and pulmonary hypertension

Jiwei Zhang

Xiaoyi Hu

Tao Wang

Rui Xiao

Liping Zhu

...

2023/11/30

Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia

Respiratory Research

Dongdong Yu

Ting Zhang

Guangyuan Zhou

Zeang Wu

Rui Xiao

...

2023/4/8

Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation

Frontiers in Cardiovascular Medicine

Amine Nasri

Jocelyn Dupuis

Michel Carrier

Normand Racine

Marie-Claude Parent

...

2022/12/2

Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure

ESC Heart Failure

Valéry Legris

Bernard Thibault

Jocelyn Dupuis

Michel White

Anita W Asgar

...

2022/2

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke–Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFκB (Nuclear Factor κB …

Hypertension

Yuan Su

Rubin Tan

Mengxiang Sun

Linbo Yuan

Matthieu Ruiz

...

2022/12

Fourteen-day evolution of COVID-19 symptoms during the third wave in nonvaccinated subjects and effects of hesperidin therapy: a randomized, double-blinded, placebo-controlled …

Evidence-Based Complementary and Alternative Medicine

Jocelyn Dupuis

Pierre Laurin

Jean-Claude Tardif

Leslie Hausermann

Camille Rosa

...

2022/11/3

Orally‐administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers

Clinical and Translational Medicine

Rui Xiao

Jie Liu

Shengquan Luo

Zhe Yu

Jiwei Zhang

...

2022/9

Calcium sensing receptor variants increase pulmonary hypertension susceptibility

Hypertension

Bingxun Liu

Yun-Peng Wei

Xiaohang Fan

Xiaoyi Hu

Zeshuai Chen

...

2022/7

Long-chain acylcarnitines and monounsaturated fatty acids discriminate heart failure patients according to pulmonary hypertension status

Metabolites

Maxime Tremblay-Gravel

Annik Fortier

Cantin Baron

Chloé David

Pamela Mehanna

...

2021/3/26

SPECT imaging of pulmonary vascular disease in bleomycin-induced lung fibrosis using a vascular endothelium tracer

Respiratory Research

François Harel

Quang T Nguyen

Mohamed J Nsaibia

Vincent Finnerty

Arielle Morgan

...

2021/12

Efficacy of colchicine in non-hospitalized patients with COVID-19

Medrxiv

Jean-Claude Tardif

Nadia Bouabdallaoui

Philippe L L’Allier

Daniel Gaudet

Binita Shah

...

2021/1/27

Peptide blocking self-polymerization of extracellular calcium-sensing receptor attenuates hypoxia-induced pulmonary hypertension

Hypertension

Rui Xiao

Shengquan Luo

Ting Zhang

Yankai Lv

Tao Wang

...

2021/11

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

The Lancet Respiratory Medicine

Jean-Claude Tardif

Nadia Bouabdallaoui

Philippe L L'allier

Daniel Gaudet

Binita Shah

...

2021/8/1

Dietary geranylgeranyl pyrophosphate counteracts the benefits of statin therapy in experimental pulmonary hypertension

Circulation

Liping Zhu

Fangbo Liu

Qiang Hao

Tian Feng

Zeshuai Chen

...

2021/5/4

Right Ventricular Function Coupling to the Pulmonary Circulation Predicts Exercise Tolerance in Patients with Heart Failure and Reduced Ejection Fraction. Insight from the …

The Journal of Heart and Lung Transplantation

Valéry Legris

Bernard Thibault

Jocelyn Dupuis

Michel White

Annik Fortier

...

2020/4/1

PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure

Cardiovascular Research

Quang T Nguyen

Mohamed J Nsaibia

Martin G Sirois

Angelino Calderone

Jean-Claude Tardif

...

2020/1/1

Colchicine reduces lung injury in experimental acute respiratory distress syndrome

PLoS One

Jocelyn Dupuis

Martin G Sirois

Eric Rhéaume

Quang T Nguyen

Marie-Élaine Clavet-Lanthier

...

2020/12/2

A novel molecular pathway of plaque vulnerability reveals a cholesterol-independent effect of statins and supports inflammation as a therapeutic target

Pauline Mury

Jocelyn Dupuis

Eric Thorin

2020/11

Benefits of PBI-4425 on Acute Respiratory Failure in Oleic Acid-Induced Lung Injury

J Dupuis

QT Nguyen

MJ Nsaibia

MG Sirois

B Grouix

...

2020/5

See List of Professors in Jocelyn Dupuis University(Université de Montréal)

Co-Authors

H-index: 182
Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

University of Salford

H-index: 146
Rouleau J

Rouleau J

Université de Montréal

H-index: 134
Mark T. Gladwin

Mark T. Gladwin

University of Pittsburgh

H-index: 110
Stephen L. Archer

Stephen L. Archer

Queen's University

H-index: 102
Nicholas Morrell

Nicholas Morrell

University of Cambridge

academic-engine